[HTML] mdpi.com

[HTML][HTML] Biological rationale for targeting MEK/ERK pathways in anti-cancer therapy and to potentiate tumour responses to radiation

F Marampon, C Ciccarelli, BM Zani - International journal of molecular …, 2019 - mdpi.com
ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are evolutionary-
conserved and ubiquitous serine-threonine kinases involved in regulating cell signalling in …
被引用次数：62 相关文章
[HTML] nih.gov

[HTML][HTML] Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation

F Marampon, C Ciccarelli, BM Zani - International Journal of …, 2019 - ncbi.nlm.nih.gov
Abstract ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are
evolutionary-conserved and ubiquitous serine-threonine kinases involved in regulating cell …

Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation

F Marampon, C Ciccarelli… - International Journal of …, 2019 - search.proquest.com
impairments in MAPK signalling pathways are reported in a range of human diseases,
including cancer and neurodegenerative disorders such as Alzheimer's disease …
[PDF] semanticscholar.org

[PDF][PDF] Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation

F Marampon, C Ciccarelli, BM Zani - Int. J. Mol. Sci, 2019 - pdfs.semanticscholar.org
ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are
evolutionaryconserved and ubiquitous serine-threonine kinases involved in regulating cell …

Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation

F Marampon, C Ciccarelli… - International journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are evolutionary-
conserved and ubiquitous serine-threonine kinases involved in regulating cell signalling in …

Biological rationale for targeting MEK/ERK pathways in anti-cancer therapy and to potentiate tumour responses to radiation

F Marampon, C Ciccarelli, BM Zani - … JOURNAL OF MOLECULAR …, 2019 - iris.uniroma1.it
Abstract ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are
evolutionary-conserved and ubiquitous serine-threonine kinases involved in regulating cell …

Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation

F Marampon, C Ciccarelli, BM Zani - 2019 - agris.fao.org
ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are evolutionary-
conserved and ubiquitous serine-threonine kinases involved in regulating cell signalling in …

Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation.

F Marampon, C Ciccarelli… - International Journal of …, 2019 - search.ebscohost.com
Abstract ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are
evolutionary-conserved and ubiquitous serine-threonine kinases involved in regulating cell …

Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation.

F Marampon, C Ciccarelli, BM Zani - International Journal of …, 2019 - europepmc.org
Abstract ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are
evolutionary-conserved and ubiquitous serine-threonine kinases involved in regulating cell …
[PDF] academia.edu

[PDF][PDF] Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation

F Marampon, C Ciccarelli, BM Zani - Int. J. Mol. Sci, 2019 - academia.edu
ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are
evolutionaryconserved and ubiquitous serine-threonine kinases involved in regulating cell …